Peabody Announces First Coal Shipment from Centurion Mine

2024-12-18 Peabody HaiPress

Marks another major milestone in the redevelopment of the premiumsteelmaking coal mine

ST. LOUIS,Dec. 17,2024 --Peabody (NYSE: BTU) today announced that it has successfully shipped the first product from its Centurion Mine in Queensland's Bowen Basin,marking another major milestone in the redevelopment of the premium hard coking coal mine.

The inaugural shipment was delivered to the Dalrymple Bay Coal Terminal and loaded for export to a customer in Asia last week. This achievement highlights Centurion's ongoing ramp up toward higher-volume longwall production that is targeted to begin in March 2026.

"Two years ago,we announced the redevelopment of this mine with a plan to transform it into a world-class operation supplying premium hard coking coal to global markets,and this week we're delivering on that plan," Jim Grech,Peabody President and Chief Executive Officer,said. "This is the first strategic step in transforming Peabody into a primarily metallurgical coal producer,and we are proud of the strong progress being made."

With a planned annual production averaging 4.7 million tons and approximately 140 million tons of reserves,the operation has a mine life of more than 25 years. The premium hard coking coal supplied from Centurion is essential to making original steel,a foundation material for hospitals,schools and bridges as well as renewable energy infrastructure like wind turbines. Centurion coal is sought after for its high coke strength and low impurities,qualities that enhance steel production efficiency and support decarbonisation in the steelmaking process.

Centurion is also advancing Peabody's commitment to sustainability with predevelopment works underway for 5 megawatt (MW) power station at the mine supporting the project's emission abatement goals by reusing waste gas from the coal seams.

In November,the company announced an agreement to acquire four Tier 1 steelmaking coal mines from Anglo American. The completion of that acquisition,intended for mid-2025,combined with the redevelopment of Centurion,accelerates Peabody's strategy to reweight its global coal portfolio and cash flows to metallurgical coal.

Peabody is a leading coal producer,providing essential products for the production of affordable,reliable energy and steel. Our commitment to sustainability underpins everything we do and shapes our strategy for the future. For further information,visit PeabodyEnergy.com.

Please find interviews and background video here and photos here.

CONTACT:


Vic Svec


+1.314.342.7890

Logo - /up/2024/1218/24121820002798922895.jpg

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map